0.3900
-0.0070
(-1.76%)
As of 12:17:01 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.4 | -0.43 | -1.75 | -1.58 |
| Low Estimate | -0.42 | -0.44 | -1.82 | -1.92 |
| High Estimate | -0.38 | -0.41 | -1.68 | -1.24 |
| Year Ago EPS | -0.52 | -0.55 | -1.99 | -1.75 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.46 | -0.41 | -0.32 | -0.36 |
| EPS Actual | -0.52 | -0.55 | -0.41 | -0.41 |
| Difference | -0.06 | -0.14 | -0.09 | -0.05 |
| Surprise % | -13.48% | -33.33% | -28.12% | -13.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.4 | -0.43 | -1.75 | -1.58 |
| 7 Days Ago | -0.4 | -0.43 | -1.75 | -1.58 |
| 30 Days Ago | -0.35 | -0.38 | -1.52 | 0 |
| 60 Days Ago | -0.35 | -0.38 | -1.52 | 0 |
| 90 Days Ago | -0.37 | -0.37 | -1.45 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NXTC | 23.37% | 22.73% | 12.06% | 9.71% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | Needham: Buy to Buy | 8/2/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/31/2024 |
Related Tickers
ASMB Assembly Biosciences, Inc.
8.72
-6.34%
KZR Kezar Life Sciences, Inc.
4.0500
-10.00%
SPRO Spero Therapeutics, Inc.
0.5968
-4.36%
HLVX HilleVax, Inc.
1.4400
-0.69%
BOLT Bolt Biotherapeutics, Inc.
0.3726
-5.77%
GLPG.AS Galapagos NV
21.76
-1.45%
PMVP PMV Pharmaceuticals, Inc.
0.9600
-3.52%
GLTO Galecto, Inc.
2.7250
-4.72%
OKUR OnKure Therapeutics, Inc.
3.3700
-13.37%
THRD Third Harmonic Bio, Inc.
3.3800
-5.31%